Astellas Pharma US, Inc.
Northbrook, IL
- UEI
- NKGHPQKJQWC1
- CAGE
- 39832
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2375 Waterview Dr, Northbrook, IL 60062, USA
- Website
- astellas.com
- Founded
- 2005
- Employees
- 10K-50K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Cipla USA Inc. | Warren, NJ | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Ascendis Pharma, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
| Sanofi Genzyme | Cambridge, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Mylan Pharmaceuticals Inc. | Morgantown, WV | 325412 Pharmaceutical Preparation Manufacturing |
| U.s. Division | Rockville, MD | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
About the company
Astellas Pharma US, Inc. is a foreign owned, for-profit pharmaceutical manufacturer registered in SAM.gov since 2002. Astellas provides pharmaceuticals and drugs to federal government agencies, primarily the Department of Veterans Affairs and the Bureau of Prisons.
Through prime contract awards, Astellas has provided specialty pharmaceuticals and life-sustaining biologic medications to support inmate healthcare at Federal Correctional Institution Beckley. Awards were made as delivery orders under the Pharmaceuticals and Drugs GSA Schedule, with no set-aside designations and potential values ranging from $13,045.98 to $41,442.72.
Astellas also holds several federal contract IDVs to provide pharmaceuticals and hematology-related products to Veterans Health Administration medical facilities. This includes a $3.5 billion Federal Supply Schedule contract for drugs and pharmaceuticals, awarded by VA VISN 12 in 2021. Two Blanket Purchase Agreements were subsequently established against this schedule by the VA's National Acquisition Center - one to facilitate purchases of the oncology drugs XTANDI and XOSPATA, valued at $296,500 through 2024; and another 2019 BPA to purchase XTANDI specifically, with a potential value of over $1 million through 2021.
Quick answers
Is Astellas Pharma US, Inc. registered in SAM.gov?
Yes. Astellas Pharma US, Inc.'s SAM.gov registration is active through June 18, 2027.
What is Astellas Pharma US, Inc.'s CAGE code?
Astellas Pharma US, Inc.'s CAGE code is 39832, and its Unique Entity ID (UEI) is NKGHPQKJQWC1.
Which contract vehicles does Astellas Pharma US, Inc. hold?
Astellas Pharma US, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Astellas Pharma US, Inc.'s most recent federal award?
Astellas Pharma US, Inc.'s most recent federal contract award is Life sustaining biologics medication for the inmate population of FCI beckley. RP#184-19 (15B10319FUB110161), from Federal Correctional Institution Beckley (BOP), on July 31, 2019.
On GovTribe
See Astellas Pharma US, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors